StockData
Damora Therapeutics, Inc. logo

Damora Therapeutics, Inc. (DMRA) stock

DMRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$22.56+0.06 (+0.29%)

Close on Nov 17, 2026Market cap $1.39BP/E 5.7Yield 0.00%

Damora Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Damora Therapeutics's price to book ratio was 2.8× on Nov 11, 2026, against 3.5× a year earlier. Over the last 5 years it ranged from 0.2× to 5.2×, with a median of 0.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.8×−1.8
2025Dec 31, 20254.6×+4.3
2024Dec 31, 20240.3×−0.2
2023Dec 29, 20230.5×+0.1
2022Dec 30, 20220.4×−0.2
2021Dec 31, 20210.6×–

More Damora Therapeutics figures

See a number that looks wrong?